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Abstract
Background: Transmitted by blood-sucking insects, the unicellular parasite Trypanosoma cruzi is the causative agent of
Chagas’ disease, a malady manifested in a variety of symptoms from heart disease to digestive and urinary tract
dysfunctions. The reasons for such organ preference have been a matter of great interest in the field, particularly because
the parasite can invade nearly every cell line and it can be found in most tissues following an infection. Among the
molecular factors that contribute to virulence is a large multigene family of proteins known as gp85/trans-sialidase, which
participates in cell attachment and invasion. But whether these proteins also contribute to tissue homing had not yet been
investigated. Here, a combination of endothelial cell immortalization and phage display techniques has been used to
investigate the role of gp85/trans-sialidase in binding to the vasculature.
Methods: Bacteriophage expressing an important peptide motif (denominated FLY) common to all gp85/trans-sialidase
proteins was used as a surrogate to investigate the interaction of this motif with the endothelium compartment. For that
purpose phage particles were incubated with endothelial cells obtained from different organs or injected into mice
intravenously and the number of phage particles bound to cells or tissues was determined. Binding of phages to
intermediate filament proteins has also been studied.
Findings and Conclusions: Our data indicate that FLY interacts with the endothelium in an organ-dependent manner with
significantly higher avidity for the heart vasculature. Phage display results also show that FLY interaction with intermediate
filament proteins is not limited to cytokeratin 18 (CK18), which may explain the wide variety of cells infected by the parasite.
This is the first time that members of the intermediate filaments in general, constituted by a large group of ubiquitously
expressed proteins, have been implicated in T. cruzi cell invasion and tissue homing.
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Introduction
Trypanosoma cruzi, the causative agent of Chagas’ disease, is an
obligatory intracellular parasite that uses mammalian host cells to
replicate and escape from the immune system to continue its life
cycle [1]. The infective trypomastigote form is transmitted to
humans (and other vertebrate hosts) by blood-sucking insects or
blood transfusion, and recently recognized, by ingestion of infected
triatomine contaminated food. Following infection, patients enter
an acute phase of the disease in which parasites are often found in
circulation, resulting in the infection of many tissues and organs.
However, in a few weeks parasites vanish from the blood and
patients enter the indeterminate or chronic stages of the disease.
The reasons why some enter an indeterminate stage and never
develop any symptoms while others evolve to the chronic
manifestations of Chagas’ disease is unknown. About two thirds
of patients with symptoms will develop heart disease and the
remaining ones gastrointestinal motor disorders, mainly a result of
enteric nervous system injury caused by the parasite [2,3,4].
Bladder and other urinary tract disorders have also been described
but much less frequently [2,5]. The exact mechanism for such
tissue and organ preference is still a matter of debate and research.
Therefore, unveiling the mechanism of parasite cell attachment
and tissue tropism is an important milestone to comprehend how
the disease develops and progress.
Toward this end, our group and others have identified and
studied a supergene family encoding the cell membrane
glycoproteins known collectively as gp85/trans-sialidase, which
involvement in trypomastigote cell entering has been well
demonstrated [1,6]. The gp85/trans-sialidases are not expressed
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by the noninfective epimastigote form of T.cruzi. There are
approximately 700 gp85/trans-sialidase genes and equal amounts
of pseudogenes, in the parasite genome of T. cruzi, Cl Brener strain
[7] and the proteins encoded by this supergene family are believed
to participle in parasite host cell adhesion and invasion by
interacting with multiple ligands, such as laminin [8], fibronectin
[9], collagen [10,11], cytokeratin (CK) [12] and probably, other
cell surface and extracellular proteins [1]. Members of the
gp85/trans-sialidase family share a signature conserved sequence
(VTVxNVxLYNR) upstream from the carboxyl terminus [13,14].
It has been shown that a peptide encoding this conserved sequence
(FLY, for short) promotes cell adhesion by binding to the
intermediate filament protein cytokeratin-18 (CK18) [12]. FLY-
promoted CK18 dephosphorylation and ERK1/2 signaling
cascade activation, significantly increasing parasite entry into
mammalian cells [15].
In the present study, it is hypothesized that the FLY peptide cell
adhesion properties could also have an important role in parasite
interaction with the vasculature in vivo, involving this peptide in
parasite tissue tropism. Inhibition of gp85/trans-sialidases with
monoclonal antibodies or anti-sense oligonucleotides block cell
invasion by T. cruzi, suggesting that these proteins contribute to
tissue infection [16,17]. To investigate whether FLY participates in
endothelial cell interaction and tissue homing, a combination of
endothelial cell immortalization and phage display methodologies
was employed. Tissue-specific microvascular endothelial cell lines
from the H-2K(b)-tsA58 mouse (termed ImmortoMouse) were
used; this cell culture system was initially established to examine
factors regulating angiogenesis and tumor cell arrest in different
organ systems [18] and it has been successfully utilized to screen
and to identify tissue homing peptides [19]. These endothelial cells
carry a temperature sensitive SV40 large T antigen under the
major histocompatibility complex H-2Kb promoter and are
conditionally immortal when cultured under permissive temper-
atures [20,21]. Of note, when cultured in vitro these cells retain at
least some of the molecular expression profile displayed in vivo
[19,21]. Combined with phage display [22], which is a powerful
tool to interrogate the vascular expression profile and more
importantly, tissue accessibility [23,24] these methodologies
constitute an experimental framework for discovery and validation
of vascular-directed receptor-pair ligands [25]. Using that strategy,
it is shown here that the FLY domain has a preference for the
vasculature of certain organs, results which might have important
implications in Chagas’ disease pathology and progression.
Materials and Methods
Reagents, recombinant proteins and synthetic peptides
Anti-fd bacteriophage antibody (Sigma Aldrich), recombinant
cytokeratin 18, cytokeratin 8, cytokeratin 20 and vimentin were
commercially obtained (Cell Sciences). Peptides were obtained by
the solid-phase peptide synthesis strategy as previously described
[12] using the Fmoc-procedure in an automated bench-top
simultaneous multiple solid-phase peptide synthesizer (PSSM 8
system from Shimadzu, Tokyo, Japan).
Cell culture
Organ derived endothelial cells were cultured and propagated
in DMEM medium (Invitrogen) supplemented with 10% fetal
bovine serum at 33uC in 5% CO2 as described [21]. For the cell
binding assays, the endothelial cells were first returned to the
quiescent state by culturing at 37uC for 48 h.
Phage mutagenesis
Phage displaying the FLY (VTVTNVFLYNRPLN) or FAY
(VTVTNVFAYNRPLN) peptide sequences were cloned in the
fUSE5 vector as previously described [22,26]. Briefly, 500 ng from
the synthetic oligonucleotides (FLY: 59-CAC TCG GCC GAC
GGG GCT AGC GTG ACC GTG ACC AAC GTG TTT CTG
TAT AAC CGC CCG CTG AAC GGG GCC GCT GGG GCC
GAA-39; FAY: 59-CAC TCG GCC GAC GGG GCT AGC GTG
ACC GTG ACC AAC GTG TTT GCG TAT AAC CGC CCG
CTG AAC GGG GCC GCT GGG GCC GAA-39) were
converted to dsDNA by PCR with the primer set 59-TTC GGC
CCC AGC GGC-39 and 59-GTG AGC CGG CTG CCC-39
(Invitrogen) and Taq-DNA polymerase (Promega). dsDNA inserts
were then purified, digested with BglI, purified again, and ligated
into a SfiI-digested fUSE5 vector. Select phage clones were
analyzed for the presence of insert and confirmed by DNA
sequencing.
Binding assays
Cell phage binding assays were performed as described [27,28].
A total of 106 cells were incubated in DMEM medium with 109
phage particles of the FLY, FAY or fd-tet phage at room
temperature for 2 h. Cell-bound phage was separated from
unbound phage by a single centrifugation method named BRASIL
(Biopanning and Rapid Analysis of Selective Interactive Ligands)
selection [27] and total DNA were extracted with the DNeasy
blood and tissue kit as described by the manufacturer (Qiagen).
The number of phage particles bound to cells and the
quantification of cells DNA were performed by qPhage [28]. For
the intermediate filament protein binding assay, recombinant
proteins were coated on microtiter (50 mL of 1 mg/mL in PBS)
overnight at 4uC. Wells were washed twice with PBS, blocked with
PBS containing 3% BSA for 2 h at room temperature, and
incubated with 109 phage particles of the individual phage in
50 mL of PBS containing 1.5% BSA. After 3 h at room
temperature, wells were washed 10 times with PBS, and phage
DNA was extracted with the DNeasy blood and tissue kit as
described by the manufacturer (Qiagen) [28].
Author Summary
Chagas’ disease, caused by the protozoon Trypanosoma
cruzi, is an ailment affecting approximately 12–14 million
people in Iberoamerica and is becoming increasingly
important in North America and Europe as a result of
migratory currents. The parasite invades mainly cells of the
heart or the walls of the digestive tract. The patients with
symptoms develop heart disease or gastrointestinal motor
disorders. We and others have implicated the T. cruzi gp85/
trans-sialidase surface protein family in the attachment of
the parasite to the host cells. These proteins share a
peptide motif called FLY. The involvement of FLY in
parasite interaction with endothelial cells from different
organs has been studied using bacteriophages expressing
the FLY peptide as surrogates. We found that phages
expressing FLY bind to endothelial cells in an organ
dependent manner, particularly in the heart. Also, this
peptide binds strongly to intermediate cell filaments, like
cytokeratins and vimentin. These results indicate that FLY
might be an important contributor to tissue tropism. It also
supports the notion that the vasculature and the
endothelial cells are important players in Chagas’ disease.
These data may have important implications in the
pathology of Chagas’ disease and novel therapeutic
approaches for patients afflicted with this disease.
Trypanosma cruzi vascular homing peptide
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Phage in vivo homing
All animal experiments were conducted according to protocols
approved by the National Institutes of Health Animal Care and Use
Committee of the University of Texas MD Anderson Cancer
Center (MDACC) and Instituto de Quı´mica, Universidade de Sa˜o
Paulo (IQ/USP). Female C57/BL6 mice were obtained from
Charles Rivers and housed in the animal facility of the MDACC or
bred in house under barrier conditions at the animal care facility of
IQ/USP. Mice were anesthetized with 2,2,2-tribromoethanol
(Avertin - 0.017 mg/g) and then injected intravenously into the
tail vein with 1010 FLY, FAY or fd-tet phage particles [19]. Each
cohort had three animals and each received a phage clone. After
30 min of phage circulation, mice were perfused through the heart
with 10 ml of DMEM. Organs were then weighed and total DNA
was extracted with DNeasy blood and tissue kit (Qiagen). The
number of bound phage and the DNA content from cells was
determined by real-time PCR as described previously [28].
Fluorescence assays
For immunofluorescence, the cells grown on a 24-well
polystyrene plate were washed with PBS two times and when
needed were fixed with 2% p-formaldehyde in ice-cold PBS for
10 min. The fixed cells were then washed three times with PBS
and permeabilized with 0.1% Triton X-100 in PBS for 5 min,
washed again with PBS three times, and blocked with PBS with
1% bovine serum albumin for 1 h at room temperature. The cells
were incubated with mouse anti-Pan Cytokeratin (1:1000 dilution)
and goat anti-Vimentin (1:20 dilution) for 1 h at room
temperature. After three washes with PBS, the cells were
incubated with Alexa-Fluor 488 conjugated to donkey anti-goat
IgG or Alexa-Fluor 594-conjugated goat anti-mouse IgG (Invitro-
gen) at a dilution of 1:1,000 for 45 min. The cells were washed and
counterstained with 1 mM 4,6-diamidino-2-phenylidole (DAPI)
before mounting with Vectashield anti-fading medium (Vector
Laboratories). The cells were visualized with an Olympus IX-71
inverted fluorescence microscope. Serial images (0.2 mm) were
acquired with a Photometrix Cool-SnapHQ charge-coupled
device camera driven by DeltaVision software (Applied Precision).
Alternatively, serial images (0.2-mm Z-increment) were collected
using a 100X objective 1.40 NA using the Cell‘M software
(Olympus Europe) in a motorized Olympus IBX81 microscope.
All images were obtained using the same acquision parameters
(exposure time, minimal and maximal gain). The images were
processed by blind deconvolution using Autoquant X 2.1.
Results
Bacteriophage as a surrogate of the FLY peptide
To generate a filamentous bacteriophage (Fd) displaying the
FLY peptide (FLY phage, for short), phage were genetically
engineered to express the VTVTNVFLYNRPLN peptide in the
outer coat of the virion particle fused to the amino-terminal
portion of the pIII minor coat protein. A mutagenized version of
the FLY phage was also constructed by substitution of the first
leucine residue in the FLY peptide for alanine, previously shown to
abolish binding to CK18 [12]. The phage displaying the peptide
VTVTNVFAYNRPLN was used as control (FAY phage, for
short). To assess whether the FLY phage retains cell and CK18
binding properties, phage binding assays were utilized. Indeed,
FLY phage binds to immobilized CK18 (Figure 1a) and to LLC-
MK2 cells cultured in microtiter wells (Figure 1b). No significant
binding of insertless fd-tet or control FAY phage to either CK18 or
LLC-MK2 cells was observed. To confirm that binding was
mediated by the displayed peptide, FLY phage binding to
immobilized CK18 was repeated in the presence of increasing
concentrations of the cognate synthetic FLY peptide or its
mutagenized version (FAY). Only synthetic soluble FLY peptide
inhibited phage binding in a dose dependent manner (Figure 1c)
and there was no effect of the FAY peptide on FLY phage binding
to CK18. In sum, the peptide VTVTNVFLYNRPLN could be
successfully displayed on the surface of filamentous phage and the
displayed peptide retained CK18 and cell binding properties.
Thus, FLY phage can be utilized as a surrogate to study
VTVTNVFLYNRPLN peptide interaction with endothelial cells
and the vascular bed.
The FLY peptide binds to endothelial cells in an organ-
dependent manner
Having shown that the peptide displayed on the surface of the
bacteriophage maintains its biological properties, the FLY phage
was then used to evaluate VTVTNVFLYNRPLN role in gp85/
trans-sialidase endothelial cell interaction. With that purpose in
mind, advantage has been taken of a previously described panel of
organ-derived immortalized endothelial cells [21], which have
been successfully combined with phage display. A screening on the
lung-derived endothelial cell line belonging to this panel led to a
peptide that homes the lung vasculature in vivo [19]. Here,
selection of endothelial cells from this panel was based on tissues to
which T. cruzi shows selective tropism in humans and animal
Figure 1. The FLY phagemimics the VTVTNVFLYNRPLN peptide. (a) Binding of FLY phage and fd-tet to immobilized CK18 and to (b) LLC-MK2
cells. (c) Binding of FLY phage to CK18 in the presence of increasing concentrations of VTVTNVFLYNRPLN synthetic peptide (FLY, black squares) or the
alanine mutagenized version VTVTNVFAYNRPLN synthetic peptide (FAY, open triangles). Results are show as percentage of binding relative to FLY
phage in the absence of peptides. Shown are standard error of the mean (SEM) of two biological replicates performed in triplicate.
doi:10.1371/journal.pntd.0000864.g001
Trypanosma cruzi vascular homing peptide
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models: heart, and the digestive and urinary tracts [3,4,5,26]. We
thus selected heart, bladder and colon derived endothelial cells.
Despite our best efforts, esophagus derived endothelial cells could
not be maintained in culture and, therefore, were not used. Lung
and bone marrow endothelial cells were included for comparison.
The endothelial cells were incubated individually with FLY, FAY
of fd-tet phage and cell bound phage separated in a single
centrifugation step, as described [27]. The results of two
independent experiments showed that FLY phage binds strongly,
in dose dependent manner, to endothelial cells derived from two
organs in which parasites can be found following infection: heart
and bladder [5,26]. FLY phage also bound, to a lesser extent, to
endothelial cells derived from the colon (Figure 2), which is
another organ affected by T. cruzi infection [4]. In contrast, and as
a sign of specificity, FLY phage bound very weakly to bone
marrow derived endothelial cells and no significant binding to lung
derived cells could be detected. No significant cell phage binding
was observed when the cells were incubated with either FAY
phage or the fd-tet insertless control phages. These data suggest
that the FLY peptide mediates T. cruzi interaction with endothelial
cells in a tissue and organ selective manner.
The FLY peptide homes in vivo
Phage display in vivo is a valuable tool to study vascular ligand-
receptor pairs [24]. This approach allows the investigator to probe
for receptor expression and accessibility in vivo without or with
minimal disturbance to the homeostasis of the vascular bed. And
because phages are large particles, they remain confined to the
circulatory system mimicking the conditions to which T. cruzi is
exposed while in circulation such as shear-stress forces. To assess
whether FLY peptide interaction with the endothelial cells is
recapitulated in vivo, mice were injected i.v. with FLY-phage and
after 30 minutes in circulation the number of phage particles
present in different tissues was determined [23,28]. FLY phage
bound to the vasculature of almost all organs analyzed (Figure 3),
which again, is in good agreement with the observation that in the
early stages of the disease, T. cruzi is found in almost every tissue
and organ [26,29]. No significant binding of FAY and fd-tet
phages was observed indicating that FLY phage interaction with
the vasculature is specific. Noteworthy, however, was the fact that
FLY phage bound very strongly to the heart vasculature with an
8,800– fold enrichment when compared to the fd-tet control phage
(Figure 3). Significant enrichment of phage particles was also
observed with the bladder and esophagus vasculature (213 and
123 times, respectively, relatively to fd-tet), and to a lesser extent,
to skeletal muscle endothelium (40 times relative to fd-tet).
Megaesophagus is a less common but also important manifestation
of Chagas’ disease [2,4]. No significant phage enrichment was
detected in the brain, which is in agreement with the lack of
disturbances in the high nervous system in patients with Chagas’
disease. Interestingly FLY phage did not seem to home in vivo to
the colon. This is not in agreement with the cell binding data,
which showed that FLY phage binds to colon-derived endothelial
cells and with the fact that megacolon is the most common
manifestation in patients afflicted with Chagas’ gastrointestinal
disorders. One possible explanation for this conundrum might be
related to the number of receptors present in the colon
vasculature. The binding of FLY phage to colon endothelial cells
was significantly weaker if compared to binding to heart and
bladder derived endothelial cells. In sum, phage display in vivo data
confirmed that FLY phage bind strongly to heart, esophagus and
bladder endothelium, which is in good agreement with the results
of the cell binding in vitro assay and suggest that parasite interaction
with the endothelium might be an important contributor to the
tropism observed in T. cruzi infection.
The FLY peptide binds to different cytokeratin family
members
There have been several reports that CK18 is expressed on the
surface of cells ([12] and references therein). However, CK18
expression profile is restricted to certain tissues and organs, which
is not in good agreement with the almost pan-infective
Figure 2. FLY phage binding to organ-derived endothelial cells. Binding of FLY phage to bone marrow, bladder, heart or lung-derived
endothelial cells; fd-tet and FAY phage were used as control. Phage binding was normalized to endothelial cell DNA, quantified using ribosomal RNA
specific probes. The error bars are standard error of the mean (SEM) of experiments performed in triplicate. Where indicated, * denotes P,0.05.
doi:10.1371/journal.pntd.0000864.g002
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characteristic of T. cruzi (the parasite can invade almost any cell
line in culture). Because cytokeratins belong to a large multigene
family with at least 34 known genes in humans and given the high
similarity among the different cytokeratin family members, we
asked whether the FLY peptide could interact with distinct
cytokeratins. The FLY phage was again used as a surrogate of the
peptide and binding to cytokeratin-8 (CK8), expressed by heart
muscle cells [30], and CK20, which is abundantly expressed by
colon epithelial cells, was performed. Vimentin, another interme-
diate filament protein expressed by endothelial cells, was also
included in the assay. The intermediate filament proteins were
immobilized on microtiter plates and incubated with FLY, FAY or
fd-tet phage as described in experimental procedures. Interesting-
ly, significant phage binding was observed to all proteins tested
(Figure 4). The interaction was specific since it could be blocked by
the cognate synthetic FLY peptide but not by its mutagenized
soluble version (FAY) (Figure 1c); and no significant binding was
observed when FAY or fd-tet control phage were incubated with
the immobilized proteins. FLY phage bound more avidly to
vimentin and to CK18 or CK20, but it also bound to CK8,
although to a lesser extent. No significant binding to BSA was
detected. These results suggest that the FLY peptide binds to
distinct members of the cytokeratin family and, perhaps, to
multiple ligands belonging to the family of intermediate filament
proteins.
Cytokeratins and vimentin are exposed on some
endothelial cells
Cytokeratins and vimentin are usually recognized as intracel-
lular components of the cytoskeleton, although previous studies
have demonstrated the presence of vimentin and cytokeratins on
the surface of vascular cells and cardiomyocytes [31]. In order to
assess whether these proteins are found on the extracellular milieu,
more specifically, on the cell surface of the organ derived
endothelial cells used in this study, immunofluorescence experi-
ments were performed. Live cells were incubated with anti-pan
cytokeratin or anti-vimentin antibodies. In agreement with the
phage binding data, significant labeling with both antibodies were
observed for the bladder, heart and the colon endothelial cells but
not with the lung derived endothelial cells (Figure 5a). As a further
proof of specificity, when cells were previously fixed with p-
formaldehyde, permeabilized with 0.1% Triton X-100 and then
incubated with the antibodies, a strong positive labeling was
observed with all cells, including the lung endothelial cells
Figure 3. FLY binding to the vasculature of the mouse. FLY and FAY phage homing in vivo was evaluated following intravenous phage
administration into mice. The number of phage particles that accumulated in the vasculature of select organs was quantified by qPhage. Results are
shown relative to the amount of mouse genomic DNA (quantified using ribosomal RNA specific probes) with the SEM of experiments performed in
triplicate. Where indicated, * denotes P,0.05.
doi:10.1371/journal.pntd.0000864.g003
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(Figure 5b). These data indicate that bladder, colon and heart
derived endothelial cells express CKs and vimentin on the cell
surface and further suggest that the preferential binding of FLY-
phage to these cells may be due, at least in part, to the presence of
extracellular exposed intermediate filament proteins.
Discussion
The role of the gp85/trans-sialidases in T. cruzi infection has been
extensively demonstrated by several groups, including ours,
although the exact mechanism by which the members of this large
gene family mediate parasite cell invasion is still unclear. Different
molecules have been identified as putative ligands for gp85/trans-
sialidase family members and the pan-specificity toward so many
distinct proteins has been explained by the existence of hundreds of
gp85/transialidases sharing variable degrees of similarity: different
proteins, different ligands. This hypothesis is corroborated by
findings, for example, from our group that only a sub-set of acidic
gp85/trans-sialidase glycoproteins binds to laminin-1 [8]. However,
in contrast with this line of thought, a highly conserved peptide
sequence present in all gp85/trans-sialidase family members
promotes organ-selective endothelial cell binding, possibly, by
interacting with different intermediate filament proteins, in
particular, those belonging to the cytokeratin family or to vimentin.
Intermediate filaments are important components of the
cytoskeleton, present in nearly every eukaryotic cell [32]. They
are comprised of proteins structurally related, including cytoker-
atins, vimentin and nuclear lamins. The binding of the FLY
peptide to different cytokeratins is not unexpected given the high
similarity among family members. But the interaction of FLY
peptide with vimentin is an interesting finding and suggests that
FLY might bind to intermediate filament proteins in general. And
since intermediate filament proteins share a common structure
and cellular functions [32] but their expression pattern vary, it is
possible that T. cruzi selected a common binding site shared by
different intermediate filament proteins in order to invade a wider
variety of cells and tissues. Our data is in agreement with this
hypothesis as suggested by the interaction of FLY peptide with
CK8 (expressed by muscle cells, epithelial cells), CK20 (epithelial
cells) and vimentin (endothelial cells). However, we cannot rule out
the participation of other intermediate filament proteins as
putative receptors for the parasite because many of these structural
proteins have overlapping expression patterns and are often
expressed by different cells in multiple tissues. For example,
cytokeratin intermediate filaments are heteropolymers formed
from equal amounts of type I and type II keratin chains. In fact,
the heterodimeric nature of cytokeratin filaments may also explain
why parasites still enter cells in which only CK18 expression has
been reduced by transient RNA interference [33].
Other studies have already pointed to the presence and
importance of cytokeratins in non-epithelial tissues, and more
specifically, the heart. Cardiac myocytes express CK8, CK18 and
CK19 [30], including the myocardial endothelium compartment
[34]; absence of CK19 results in loss of contractile force and
myopathy [35]. CK18 and a fragment of CK18 (produced by
caspase cleavage) have also been reported as markers for myocardial
damage [34,36,37]. Interestingly, the caspase cleaved-CK18
fragment seems to accumulate in myocardial lysosomes [34] and
because these organelles have a prominent role in parasite cell
entering [38], it is tempting to speculate that there might exist a
correlation between these two phenomena. In summary, our data
point to an important role of intermediate filament proteins in T.
cruzi cell entering and infection. These proteins, however, are
ubiquitously expressed by virtually all eukaryotic cells and new
approaches ought to be considered in order to fully appreciate their
individual contribution to Chagas’ disease.
Figure 4. FLY phage interaction with intermediate filament proteins. Phage binding to immobilized cytokeratin-8 (CK8), -18 (CK18) and -20
(CK20), and to vimentin. The FAY and fd-tet phage were used as control. Shown are SEM of experiments performed in triplicate. Where indicated, *
denotes P,0.05.
doi:10.1371/journal.pntd.0000864.g004
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Finally, using phage as a surrogate and a well established in vivo
homing assay, we show that the FLY peptide mediates phage
distribution to different organs of the mouse with remarkable
parallel to the tissue tropism observed in human disease and
animal models [3,4,5,39]. Worth mentioning is the strong binding
of FLY phage to the heart vasculature, one of the most affected
Figure 5. Vimentin and cytokeratin are present on the cell surface. Different organ derived endothelial cells were incubated with anti-pan-CK
(red) or anti-vimentin (green) specific antibodies. In (a), antibodies were incubated with live cells and in (b), the antibodies were incubated with p-
formaldehyde fixed and detergent permeabilized cells. DAPI staining (blue), merged fluorescence images and the corresponding DIC images are also
shown.
doi:10.1371/journal.pntd.0000864.g005
Trypanosma cruzi vascular homing peptide
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organs in patients with symptoms of chronic Chagas’ disease.
Almost 70% of the patients show some form of heart dysfunction
and die of cardiac problems [3]. These results indicate that the
FLY peptide might be an important contributor to tissue tropism,
delivering a higher load of parasite to these tissues. It also supports
the notion that the vasculature and the endothelial cells are
important players in Chagas’ disease. Taken together, our data on
endothelial cell immortalization and phage display unveiled the
important contribution of two large families of proteins, the
intermediate filament proteins and the gp85/transialidases, in T.
cruzi tissue tropism. These data may have important implications
in the pathology of Chagas’ disease and novel therapeutic
approaches for patients afflicted with this disease.
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